Provided by Tiger Trade Technology Pte. Ltd.

Biogen

216.65
-1.8500-0.85%
Post-market: 219.002.35+1.08%17:06 EDT
Volume:830.99K
Turnover:180.42M
Market Cap:31.99B
PE:38.48
High:218.89
Open:216.47
Low:213.58
Close:218.50
52wk High:222.85
52wk Low:133.53
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.48
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.70
PE(LYR):24.65

Loading ...

Biogen, Eisai announce positive recommendation for Leqembi in Canada

TIPRANKS
·
3 hours ago

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
3 hours ago

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Aug 26

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Biogen is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Aug 25

RBC Capital Adjusts Price Target on Biogen to $260 From $240

MT Newswires Live
·
Aug 25

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live
·
Aug 24

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

TIPRANKS
·
Aug 24

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS
·
Aug 24

How Investors Are Reacting To Biogen (BIIB) Raising EPS Guidance On Late-Stage Drug Trial Milestones

Simply Wall St.
·
Aug 23

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

TIPRANKS
·
Aug 22

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Reuters
·
Aug 20

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19